Prostate Cancer

Adverse events experienced by men with prostate cancer varied considerably based on the treatment they received, results of a 10-year follow-up study showed.

More than 130,000 cancer cases went undiagnosed during the first 10 months of the COVID-19 pandemic, researchers estimated in a cross-sectional analysis published in JAMA Oncology.

Transgender women are significantly less likely than cisgender men to undergo prostate cancer screening, findings suggest, and the principal driver of the disparity appears to be whether physicians recommended testing — not access to care.

Certain natural compounds derived from soy and other plants can significantly reduce the risk for breast cancer recurrence or death, data published in JNCI Cancer Spectrum suggest.

Prostate cancer survivors consuming plant-based diets had better scores for sexual function, vitality, urinary obstruction and incontinence than those on animal-based diets, study results published in Cancer showed.

Low-value care can result in significant harm and costs to patients, although interventions involving patient and clinician education could help reduce these services, an expert said.

Researchers have harnessed the ability of some molecules to vibrate strongly when stimulated by light, potentially laying the groundwork for a new approach to destroying cancer cells.

Researchers at The Ohio State University have harnessed artificial intelligence machine learning processes to inform and support timely treatment decision-making in prostate cancer.

Rates of wellness visits and preventive health screenings remain below pre-COVID-19 pandemic levels, particularly among diverse groups, according to a recent study.

Active and former marijuana users reported significantly lower prevalence of prostate cancer compared with nonusers, according to data presented at ASCO Genitourinary Cancers Symposium.